DK177298B1 - Nucleic Acid and Amino Acid Sequences of Infectious Salmon Anaemia Virus and their Use as Vaccines - Google Patents

Nucleic Acid and Amino Acid Sequences of Infectious Salmon Anaemia Virus and their Use as Vaccines Download PDF

Info

Publication number
DK177298B1
DK177298B1 DKPA200200167A DKPA200200167A DK177298B1 DK 177298 B1 DK177298 B1 DK 177298B1 DK PA200200167 A DKPA200200167 A DK PA200200167A DK PA200200167 A DKPA200200167 A DK PA200200167A DK 177298 B1 DK177298 B1 DK 177298B1
Authority
DK
Denmark
Prior art keywords
nucleic acid
acid sequences
isav
sequences
amino acid
Prior art date
Application number
DKPA200200167A
Other languages
English (en)
Inventor
Steven Griffiths
Rachel Jane Ritchie
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK177298(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9918588.6A external-priority patent/GB9918588D0/en
Priority claimed from GB0005848A external-priority patent/GB0005848D0/en
Priority claimed from GB0006674A external-priority patent/GB0006674D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of DK200200167A publication Critical patent/DK200200167A/da
Application granted granted Critical
Publication of DK177298B1 publication Critical patent/DK177298B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Paper (AREA)
  • Color Image Communication Systems (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Den foreliggende opfindelse tilvejebringer anvendelse af nukleinsyresekvenser og/eller aminosyresekvenser ved fremstilling af en vaccine til beskyttelse af fisk mod infektiøs lakseanæmi-virus. I særdeleshed indeholder sådanne vacciner mindst én nukleinsyresekvens, som er afledt af ISAV eller syntetisk fremstillede analoger deraf, eller i det væsentlige homologe sekvenser. Disse nukleinsyresekvenser transkriberes og translateres til peptidsekvenser, som inkorporeres i en vaccinationsstrategi med henblik på at inducere et immunrespons mod overfladeantigenerne af ISAV og dermed selve ISAV. Såvel anvendelse af en vaccine mod ISAV som inkorporeringen at peptidsekvenser er således beskrevet heri.
DKPA200200167A 1999-08-07 2002-02-05 Nucleic Acid and Amino Acid Sequences of Infectious Salmon Anaemia Virus and their Use as Vaccines DK177298B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9918588.6A GB9918588D0 (en) 1999-08-07 1999-08-07 Sequence
GB0005848A GB0005848D0 (en) 2000-03-11 2000-03-11 Sequence
GB0006674A GB0006674D0 (en) 2000-03-21 2000-03-21 Sequence
PCT/GB2000/002976 WO2001010469A2 (en) 1999-08-07 2000-08-07 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines

Publications (2)

Publication Number Publication Date
DK200200167A DK200200167A (da) 2002-04-02
DK177298B1 true DK177298B1 (en) 2012-10-15

Family

ID=27255591

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00949769.4T DK1200132T4 (da) 1999-08-07 2000-08-07 Nucleinsyre-og aminosyresekvenser af infektiøs lakseanæmivirus og deres anvendelse som vacciner
DKPA200200167A DK177298B1 (en) 1999-08-07 2002-02-05 Nucleic Acid and Amino Acid Sequences of Infectious Salmon Anaemia Virus and their Use as Vaccines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK00949769.4T DK1200132T4 (da) 1999-08-07 2000-08-07 Nucleinsyre-og aminosyresekvenser af infektiøs lakseanæmivirus og deres anvendelse som vacciner

Country Status (12)

Country Link
US (7) US6919083B1 (da)
EP (2) EP1200132B2 (da)
AT (1) ATE332712T1 (da)
AU (1) AU6304100A (da)
CA (1) CA2378437C (da)
CY (1) CY1106175T1 (da)
DE (1) DE60029327T2 (da)
DK (2) DK1200132T4 (da)
ES (1) ES2267553T3 (da)
NO (1) NO328740B1 (da)
PT (1) PT1200132E (da)
WO (1) WO2001010469A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60029327T2 (de) 1999-08-07 2007-07-05 Novartis Ag Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
DK1094069T4 (da) * 1999-10-18 2008-07-21 Intervet Int Bv DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf
CA2402339C (en) * 2000-03-08 2010-01-12 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
AU2001295584A1 (en) * 2000-09-28 2002-04-08 Akzo Nobel N.V. Matrix proteins m1 and m2 of infections salmon anaemia virus
GB0216414D0 (en) 2002-07-15 2002-08-21 Novartis Ag Organic compounds
CA2687208C (en) 2006-12-22 2017-02-14 Soluciones Biotecnologicas Innovacion Ltda Process and formulation for immunizing fish in aquaculture systems
WO2011041789A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
SG11201405447QA (en) * 2012-03-09 2014-10-30 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311648B1 (no) 1999-05-31 2001-12-27 Genomar Asa DNA-sekvenser som kan benyttes til vaksine, forebyggende helsearbeid på fisk og akvatiske organismer og ellers innenbiomedisin, vektor, vaksine mot ILA-virus samt diagnostisk sett
DE60029327T2 (de) 1999-08-07 2007-07-05 Novartis Ag Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
DK1094069T4 (da) 1999-10-18 2008-07-21 Intervet Int Bv DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf
AU3539401A (en) 2000-01-07 2001-07-16 Akzo Nobel N.V. Vaccine for prevention and/or prophylaxis of infectious salmon anaemia in fish
CA2402339C (en) 2000-03-08 2010-01-12 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
AU2001295584A1 (en) 2000-09-28 2002-04-08 Akzo Nobel N.V. Matrix proteins m1 and m2 of infections salmon anaemia virus

Also Published As

Publication number Publication date
PT1200132E (pt) 2006-11-30
CA2378437C (en) 2014-01-21
US20100136038A1 (en) 2010-06-03
EP1637614A2 (en) 2006-03-22
EP1200132B1 (en) 2006-07-12
CA2378437A1 (en) 2001-02-15
WO2001010469A2 (en) 2001-02-15
NO20020573D0 (no) 2002-02-05
NO20020573L (no) 2002-04-05
WO2001010469A3 (en) 2001-09-07
US20040146860A1 (en) 2004-07-29
US20050261227A1 (en) 2005-11-24
DE60029327T2 (de) 2007-07-05
US7998484B2 (en) 2011-08-16
US20050164176A1 (en) 2005-07-28
US7128917B2 (en) 2006-10-31
US20120071630A1 (en) 2012-03-22
US7201910B2 (en) 2007-04-10
US7199108B2 (en) 2007-04-03
EP1200132A2 (en) 2002-05-02
DK1200132T3 (da) 2006-10-23
NO328740B1 (no) 2010-05-03
ES2267553T3 (es) 2007-03-16
EP1637614A3 (en) 2006-11-29
CY1106175T1 (el) 2011-06-08
DK200200167A (da) 2002-04-02
US6919083B1 (en) 2005-07-19
DK1200132T4 (da) 2010-04-19
ATE332712T1 (de) 2006-08-15
EP1200132B2 (en) 2010-02-17
US20070041988A1 (en) 2007-02-22
AU6304100A (en) 2001-03-05
DE60029327D1 (de) 2006-08-24

Similar Documents

Publication Publication Date Title
CY1106175T1 (el) Αλληλουχιες νουκλεϊνικου οξεος και αμινοξεος μολυσματικου ιου αναιμιας σολομων και χρηση τους ως εμβολια
JP2003528887A5 (da)
EP1064024A4 (en) VACCINES AGAINST CIRCOVIRUS INFECTIONS
WO2004001051A3 (en) Recombinant measles viruses expressing epitopes pf antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions
WO2001045639A3 (en) Methods for protecting against lethal infection with bacillus anthracis
KR20030081457A (ko) 약독된 생백신
CA2505942A1 (en) West nile virus vaccine
JP6990814B2 (ja) アヒル腸炎ウイルス及びその使用
Liu et al. DNA vaccines: mechanisms for generation of immune responses
ES2355276T3 (es) Vacunas virales mutantes y seguras.
AU2003288510A8 (en) Immunizing fish against viral infection
WO2009074861A3 (en) Improved vaccine
EP2915544B1 (en) Chimeric vaccine antigens against hepatitis c virus
ES2533345T3 (es) Diferentes serotipos del virus de la estomatitis vesicular como vectores de expresión para regímenes de inmunización
YU12991A (sh) Rekombinantne vakcine protiv kokcidioze-5-7 eimeria površinski antigen
BR0112020A (pt) Partìculas tipo vìrus de bvdv
Yu et al. Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3
DK200201270A (da) Sekvens
ATE427119T1 (de) Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
Kim et al. Generation of VHSV replicon particles carrying transmembrane and C-terminal cytoplasmic region-deleted G gene (rVHSV-GΔTM) and comparison of vaccine efficacy with G gene-deleted VHSV (rVHSV-ΔG)
FR2829498B1 (fr) Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
ATE505482T1 (de) Impfstoff gegen infektiöses lachsanämievirus
Chary et al. Protection by recombinant viral proteins against a respiratory challenge with virulent avian metapneumovirus
EP2370100A1 (en) Peptide adjuvants
Venugopal et al. Immunity to St. Louis encephalitis virus by sequential immunization with recombinant vaccinia and baculovirus derived PrM/E proteins

Legal Events

Date Code Title Description
PUP Patent expired

Expiry date: 20200807